Related Experiment Video
Updated: Jul 25, 2026
06:57
Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
Evidence of an agent transmissible from ulcerative colitis tissue
Lancet (London, England)
|June 19, 1976
Summary
Ulcerative colitis may be caused by a transmissible factor. Experiments showed that injecting animals with ulcerative colitis tissue induced similar disease changes, suggesting a transferable cause.
Area of Science:
- Gastroenterology
- Microbiology
- Immunology
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease with unknown etiology.
- Current research explores infectious or immune-mediated causes of UC.
Purpose of the Study:
- To investigate the potential role of a transmissible agent in the etiology of ulcerative colitis.
- To determine if ulcerative colitis tissue homogenates can induce similar pathological changes in animal models.
Main Methods:
- New Zealand White rabbits and A2G strain mice were inoculated with ulcerative colitis (UC) tissue homogenates.
- Inoculation routes included intracolonic, intravenous, footpad, and intraperitoneal injections.
- Control groups received homogenates from normal tissue.
Main Results:
- Rabbits inoculated with UC tissue developed histological changes in the large intestine similar to human UC.
- Mice inoculated with UC tissue developed granulomatous changes in various organs.
- No such changes were observed in animals inoculated with normal tissue homogenates.
Conclusions:
- The findings suggest a transmissible factor may be involved in the etiology of ulcerative colitis.
- Further research is warranted to identify the specific transmissible agent.
- This study provides evidence supporting an infectious or transmissible component in UC pathogenesis.
More Related Videos
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...